New Jersey S4073 requires health insurance and Medicaid coverage for Alzheimer's disease testing and treatments.
New Jersey S4073 mandates that health insurance carriers and the State Medicaid Program cover all medically necessary diagnostic testing and U.S. Food and Drug Administration-approved treatments or medications prescribed to slow the progression of Alzheimer's disease and related disorders. This coverage applies to various health insurance policies and contracts, including those for hospital and medical expense benefits.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.